A Paradigm Shift in the Prevention of Retinopathy of Prematurity

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neonatology

• Publication date

  2011-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000322848PMID 21372594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinopathy of prematurity

  2013cited by this paper
• Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

  2011cited by this paper
• Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

  2011cited by this paper
• Longitudinal Postnatal Weight Measurements for the Prediction of Retinopathy of Prematurity

  2011cited by this paper
• One-Year Survival of Extremely Preterm Infants After Active Perinatal Care in Sweden

  2011cited by this paper
• Target ranges of oxygen saturation in extremely preterm infants.

  2010cited by this paper
• The effect of recombinant human erythropoietin on the development of retinopathy of prematurity.

  2010cited by this paper
• Incidence of Retinopathy of Prematurity over the Last Decade in the Central Netherlands

  2010cited by this paper
• Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network

  2010cited by this paper
• Diabetic retinopathy: Early diagnosis and effective treatment.

  2010cited by this paper
• Blood Gases and Retinopathy of Prematurity: The ELGAN Study

  2010cited by this paper
• Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity.

  2010cited by this paper
• Use of Oxygen for Resuscitation of the Extremely Low Birth Weight Infant

  2010cited by this paper
• High or Low Oxygen Saturation and Severe Retinopathy of Prematurity: A Meta-analysis

  2010cited by this paper
• The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid.

  2010cited by this paper
• Renal and retinal effects of enalapril and losartan in type 1 diabetes.

  2009cited by this paper
• Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration

  2009cited by this paper
• Rationale for Non-Invasive Treatment of ROP: Dark Rearing Minimises Vaso-Obliteration During Hyperoxia and Mimics Physiological Vascularisation

  2009cited by this paper
• Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.

  2009cited by this paper
• One-year survival of extremely preterm infants after active perinatal care in Sweden.

  2009cited by this paper
• HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.

  2009cited by this paper
• Fresh-frozen plasma as a source of exogenous insulin-like growth factor-I in the extremely preterm infant.

  2009cited by this paper
• A Pharmacokinetic and Dosing Study of Intravenous Insulin-Like Growth Factor-I and IGF-Binding Protein-3 Complex to Preterm Infants

  2009cited by this paper
• High-Dose Erythropoietin Does Not Exacerbate Retinopathy of Prematurity in Rats

  2009influential reference
• Early Weight Gain Predicts Retinopathy in Preterm Infants: New, Simple, Efficient Approach to Screening

  2009cited by this paper
• Automated adjustment of inspired oxygen in preterm infants with frequent fluctuations in oxygenation: a pilot clinical trial.

  2009cited by this paper
• Oxygen Saturation Monitoring for the Preterm Infant: The Evidence Basis for Current Practice

  2009cited by this paper
• Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.

  2009cited by this paper
• Treatment for Retinopathy of Prematurity in Denmark in a Ten-Year Period (1996–2005): Is the Incidence Increasing?

  2008cited by this paper
• Use of Recombinant Human Erythropoietin and Risk of Severe Retinopathy in Extremely Low‐Birth‐Weight Infants

  2008cited by this paper
• Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial.

  2008cited by this paper
• Erythropoietin deficiency decreases vascular stability in mice.

  2008cited by this paper
• Elevated Erythropoietin mRNA and Protein Concentrations in the Developing Human Eye

  2008cited by this paper
• Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.

  2007cited by this paper
• Prorenin levels in retinopathy of prematurity.

  2007cited by this paper
• The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study

  2007cited by this paper
• Optimal Oxygenation at Birth and in the Neonatal Period

  2007cited by this paper
• Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

  2007influential reference
• Compliance With Alarm Limits for Pulse Oximetry in Very Preterm Infants

  2007cited by this paper
• Achieved Versus Intended Pulse Oximeter Saturation in Infants Born Less Than 28 Weeks' Gestation: The AVIOx Study

  2006cited by this paper
• Erythropoietin Concentrations and Neurodevelopmental Outcome in Preterm Infants

  2006cited by this paper
• Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity.

  2006cited by this paper
• Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities

  2006cited by this paper
• Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.

  2006cited by this paper
• A Survey of Delivery Room Resuscitation Practices in the United States

  2006cited by this paper
• Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model.

  2006cited by this paper
• Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity.

  2006cited by this paper
• The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years

  2006cited by this paper
• RETHINKING STOP-ROP: IS IT WORTHWHILE TRYING TO MODULATE EXCESSIVE VEGF LEVELS IN PRETHRESHOLD ROP EYES BY SYSTEMIC INTERVENTION?: A Review of the Role of Oxygen, Light Adaptation State, and Anemia in Prethreshold ROP

  2006cited by this paper
• The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study

  2005cited by this paper
• Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

  2005cited by this paper
• Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs

  2005cited by this paper
• Oxidative Stress in the Newborn – A 30-Year Perspective

  2005cited by this paper
• Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study.

  2004cited by this paper
• Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants.

  2004cited by this paper
• Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?

  2003cited by this paper
• HLF/HIF‐2α is a key factor in retinopathy of prematurity in association with erythropoietin

  2003cited by this paper
• Hyperglycemia and Retinopathy of Prematurity in Very Low Birth Weight Infants

  2003cited by this paper
• Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.

  2003cited by this paper
• Oxygen-saturation targets and outcomes in extremely preterm infants.

  2003cited by this paper
• Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.

  2003cited by this paper
• Erythropoietin: Physiology and Pharmacology Update 2

  2003cited by this paper
• Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.

  2003cited by this paper
• Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity.

  2002cited by this paper
• Intraretinal oxygen consumption in the rat in vivo.

  2002cited by this paper
• The Effect of Anemia on Retinopathy of Prematurity in Extremely Low Birth Weight Infants

  2001cited by this paper
• Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation

  2001cited by this paper
• Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity

  2001cited by this paper
• The role of blood transfusions and iron intake on retinopathy of prematurity.

  2001cited by this paper
• Childhood blindness in the context of VISION 2020--the right to sight.

  2001cited by this paper
• Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System

  2000cited by this paper
• Severity of Neonatal Retinopathy of Prematurity Is Predictive of Neurodevelopmental Functional Outcome at Age 5.5 Years

  2000cited by this paper
• Glucose homeostasis in the micropremie.

  2000cited by this paper
• Oxygen therapy, oxygen toxicity, and the STOP-ROP trial.

  2000influential reference
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

  2000cited by this paper
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

  1999cited by this paper
• Angiotensin II receptor subtype gene expression and cellular localization in the retina and non‐neuronal ocular tissues of the rat

  1999cited by this paper
• Reduced retinal vascularization in children with growth hormone deficiency.

  1999cited by this paper
• Limited Proteolysis of the IGF Binding Protein-2 (IGFBP-2) by a Specific Serine Protease Activity in Early Breast Milk

  1999cited by this paper
• [Retinopathy of prematurity].

  1998cited by this paper
• Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group.

  1998cited by this paper
• Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.

  1998cited by this paper
• Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials.

  1997cited by this paper
• Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.

  1997cited by this paper
• Breast-feeding and growth factors in preterm newborn infants.

  1997cited by this paper
• CHANGING PATTERNS OF RED BLOOD CELL TRANSFUSION IN VERY LOW BIRTHWEIGHT INFANTS. † 1500

  1996cited by this paper
• Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.

  1996cited by this paper
• Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

  1996cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

  1995cited by this paper
• The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis.

  1995cited by this paper
• Effect of light on oxygen-induced retinopathy in the mouse.

  1994cited by this paper
• A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity.

  1992cited by this paper
• Effective care of the newborn infant

  1992cited by this paper
• Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1991cited by this paper
• Incidence and Early Course of Retlnonathy of Prematurity

  1991cited by this paper
• Neonatal pulse oximetry: accuracy and reliability.

  1989cited by this paper
• Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia.

  1989cited by this paper
• Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.

  1989cited by this paper

• Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity

  2026influential citation
• Omega-3 Supplementation Decreases Malondialdehyde, Vascular Endothelial Growth Factor Expression, Tumor Necrosis Factor Alpha, and Vascular Tuft in Oxygen-Induced Retinopathy

  2025cites this paper
• ASSESSMENT OF NEONATAL CARE STANDARD BY THE PREDICTIVE MODEL FOR RETINOPATHY OF PREMATURITY BASED ON WEIGHT GAIN

  2023cites this paper
• Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation

  2023cites this paper
• Retinopathy of Prematurity: A Global Perspective and Recent Developments.

  2022cites this paper
• Neurodevelopmental Outcomes Associated With Intravitreal Bevacizumab Injections for Retinopathy of Prematurity

  2021cites this paper
• Vitamin E and preterm infants.

  2021cites this paper
• Incidence of retinopathy of prematurity in premature infants and its related factors

  2021cites this paper
• Strategies to Prevent Severe Retinopathy of Prematurity: A 2020 Update and Meta-analysis.

  2020cites this paper
• Frequency and risk factors of retinopathy of prematurity in preterm babies at a tertiary care hospital in Lahore

  2020cites this paper
• Update in the Treatment of Retinopathy of Prematurity

  2020cites this paper
• Enteral Docosahexaenoic Acid and Retinopathy of Prematurity: A Randomized Clinical Trial.

  2019cites this paper
• Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

  2019cites this paper
• Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

  2019cites this paper
• BINOCULARITY OUTCOMES OF LASER ABLATION VERSUS ANTI-VEGF TREATMENTS IN RETINOPATHY OF PREMATURITY

  2018cites this paper
• Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia

  2018cites this paper
• Is human milk feeding protective for Retinopathy of Prematurity?

  2018cites this paper
• Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

  2017cites this paper
• Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

  2016cites this paper
• Oral propranolol in early stages of retinopathy of prematurity

  2016influential citation
• Lower early postnatal oxygen saturation target and risk of ductus arteriosus closure failure

  2016cites this paper
• The Specificity of the WINROP Algorithm Can Be Significantly Increased by Reassessment of the WINROP Alarm

  2015cites this paper
• Therapeutic strategies for retinopathy of prematurity

  2015cites this paper
• Prävention und Therapie der Retinopathia praematurorum

  2015cites this paper
• Preventative Strategies in the Management of ROP: A Review of Literature

  2015cites this paper
• Screening And Treatment Results Of Retinopathy Of Prematurity

  2015cites this paper
• Search strategy and selection criteria

  2015cites this paper
• The Oxidative Stress in the Fetus and in the Newborn

  2014cites this paper
• Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come

  2014cites this paper
• Systemic Effects of Ophthalmic Cyclopentolate on Body Weight in Neonatal Mice

  2014cites this paper
• The Effect of a Donor Milk Policy on the Diet of Very Low Birth Weight Infants

  2014cites this paper
• Chorioamnionitis as a Risk Factor for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis

  2014cites this paper
• Perinatal and Prenatal Disorders

  2014cites this paper
• Pathogenesis of Retinopathy of Prematurity: Does Inflammation Play a Role?

  2013cites this paper
• Adherence to oxygenation and ventilation targets in mechanically ventilated premature and sick newborns: a retrospective study

  2013cites this paper
• Title Hypoxia-induced oxidative stress in ischemic retinopathy

  2013cites this paper
• Expression and function of Delta-like ligand 4 in a rat model of retinopathy of prematurity

  2013cites this paper
• Patent ductus arteriosus and indomethacin treatment as independent risk factors for plus disease in retinopathy of prematurity.

  2013cites this paper
• Influence of the difference of breastfeeding volume on a rat model of oxygen-induced retinopathy

  2013influential citation
• The Use of the WINROP Screening Algorithm for the Prediction of Retinopathy of Prematurity in a Chinese Population

  2013cites this paper
• Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis

  2013cites this paper
• In vivo retinal vascular oxygen tension imaging and fluorescein angiography in the mouse model of oxygen-induced retinopathy.

  2013cites this paper
• Retinopathy of prematurity

  2013cites this paper
• Retina In Vivo Retinal Vascular Oxygen Tension Imaging and Fluorescein Angiography in the Mouse Model of Oxygen-Induced Retinopathy

  2013cites this paper
• Hypoxia-Induced Oxidative Stress in Ischemic Retinopathy

  2012cites this paper
• Continuous glucose monitoring and retinopathy of prematurity

  2012cites this paper
• [Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options].

  2012cites this paper
• Healthcare associated infections in children-where are we now ?

  2012cites this paper
• Can peak creatininemia be used as risk indicator for retinopathy of prematurity in ELBW infants?

  2012influential citation
• Ácido docosahexaenoico y ácido araquidónico en neonatos: ¿el aporte que reciben es suficiente para cubrir sus necesidades?

  2012cites this paper
• Developing treatments for prevention of retinopathy of prematurity

  2012cites this paper
• Educational paper

  2012influential citation
• Perinatal infection, inflammation, and retinopathy of prematurity.

  2012cites this paper
• Reduction of Retinopathy of Prematurity in Extremely Low Gestational Age Newborns Treated with Recombinant Human Cu/Zn Superoxide Dismutase

  2012cites this paper
• Retinopathy of prematurity: risk factors and clinical management in a cohort of ELBW infants

  2011cites this paper
• Oxygen Saturation in Immature Babies: Revisited with Updated Recommendations

  2011cites this paper
• Retinopathy of prematurity.

  1991cites this paper